Increased ratio of circulating neutrophils to monocytes in amyotrophic lateral sclerosis
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received February 1, 2016
- Accepted in final form March 24, 2016
- First Published June 1, 2016.
Author Disclosures
- Benjamin J. Murdock, PhD*,
- Diane E. Bender, PhD*,
- Samy R. Kashlan, MD,
- Claudia Figueroa-Romero, PhD,
- Carey Backus, BS,
- Brian C. Callaghan, MD,
- Stephen A. Goutman, MD and
- Eva L. Feldman, MD, PhD
- Benjamin J. Murdock, PhD*,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Served as a temporary grant writer for the American Neurological Association. Compensation was ≤ $1000.
NONE
NONE
NONE
NONE
1) CReATe Consortium: examination the role of blood-borne NK cells in ALS pathogenesis.
NONE
NONE
NONE
NONE
NONE
NONE
- Diane E. Bender, PhD*,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Samy R. Kashlan, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Claudia Figueroa-Romero, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Katherine Rayner Fund A. Alfred Taubman Medical Research Institute
NONE
NONE
NONE
NONE
NONE
NONE
- Carey Backus, BS,
NONE
NONE
NONE
NONE
Patent: Trk C antibody, produced at UCSF
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Brian C. Callaghan, MD,
Consultant and scientific advisory board member on a PCORI grant
NONE
1) American Academy of Neurology, travel 2) World Federation of Neurology, travel
NONE
NONE
NONE
NONE
Consultant and scientific advisory board member on a PCORI grant
NONE
1.ALS Association, certify centers 2.Advance Medical, patient consultation service 3.Honoraria from the British Medical Journal
NONE
Impeto Medical Inc.
NIH K23 NS079417-01, PI, 5 year award
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Consultant for medical legal case
- Stephen A. Goutman, MD and
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) Neuralstem Protocol # NS2012-3
(1) CDC/ATSDR, Contract # 200-2013-56856, Co-Investigator, 2013 to present
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Eva L. Feldman, MD, PhD
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) Centers for Disease Control, Contract #200-2013-56856,PI, 09/01/2013-08/31/2017, (2) NIH (Prime: Emory University), RO1 NS077982, PI,09/02/2012-07/31/2016 (3) NIH/NINDS, T32 NS07222, PI, 07/01/2012-06/30/2017 (4) NIH, 1DP3DK094292, PI, 09/30/2011-09/29/2016 (5) NIH-NIDDK (CDC Contract #200-2010-35171; Prime: Wake Forest University (WFUHS 30225)), Site PI,09/30/2010-09/29/2015 (6) NIH/NIDDK, 1 R24 082841, PI, 04/01/2010- 03/31/2016 (7) NIH/NINDS, R01 NS08230401A1, Co-I, 05/01/2014-04/30/2019 (8) NIH (Prime; Direct-University of Colorado, Denver), PI, 06/01/2013-05/31/2017 (9) NIH/NINDS, K23 NS079417, Sponsor, 07/01/13-06/30/18
NONE
(1) Novo Nordisk Foundation, NNF14SA0006, PI, (2) Juvenile Diabetes Research Foundation, Sponsor, (3)Juvenile Diabetes Research Foundation, PI, (4) US-Israel Binational Science Foundation, PI, (5) American Diabetes Association, PI
NONE
NONE
NONE
NONE
NONE
NONE
- From the Department of Neurology (B.J.M., D.E.B., S.R.K., C.F.-R., C.B., B.C.C., S.A.G., E.L.F.) and A. Alfred Taubman Medical Research Institute (E.L.F.), University of Michigan, Ann Arbor.
- Correspondence to Dr. Feldman: efeldman{at}umich.edu
Article usage
Cited By...
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. David E. Vaillancourt and Dr. Shannon Y. Chiu
► Watch
Topics Discussed
Alert Me
Recommended articles
-
Article
Systemic inflammatory response and neuromuscular involvement in amyotrophic lateral sclerosisChing-Hua Lu, Kezia Allen, Felicia Oei et al.Neurology: Neuroimmunology & Neuroinflammation, June 01, 2016 -
Article
TDP-43–specific Autoantibody Decline in Patients With Amyotrophic Lateral SclerosisAnne Kallehauge Nielsen, Jonas Folke, Sylwia Owczarek et al.Neurology: Neuroimmunology & Neuroinflammation, December 24, 2020 -
Article
Randomized phase 2 trial of NP001, a novel immune regulatorSafety and early efficacy in ALSRobert G. Miller, Gilbert Block, Jonathan S. Katz et al.Neurology - Neuroimmunology Neuroinflammation, April 09, 2015 -
Article
Interleukin-15 enhances proinflammatory T-cell responses in patients with MS and EAECyril Laurent, Gabrielle Deblois, Marie-Laure Clénet et al.Neurology: Neuroimmunology & Neuroinflammation, December 15, 2020